Equillium (EQ) Accumulated Expenses (2017 - 2026)
Equillium's (EQ) quarterly Accumulated Expenses came in at $1.6 million in Q1 2026, down 42.49% year-on-year from $2.8 million in Q1 2025, and up 9.9% on a QoQ basis from $1.5 million in Q4 2025.
Equillium (EQ) Accumulated Expenses (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Accumulated Expenses data on file, last reported at $1.6 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses fell 42.49% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 42.49% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 57.97% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $1.6 million, up from $1.5 million in the prior quarter.
- Over the last five years, Accumulated Expenses for EQ reached as high as $7.2 million in Q4 2022 and fell as low as $69000.0 in Q2 2022.
- Historically, Accumulated Expenses has averaged $2.1 million across 5 years, with a median of $1.6 million in 2026.
- Across the five-year window, Accumulated Expenses tumbled 98.16% in 2022 and jumped 2568.12% in 2023, its largest moves.
- Year by year, Accumulated Expenses stood at $7.2 million in 2022, then slumped by 57.81% to $3.1 million in 2023, then grew by 14.05% to $3.5 million in 2024, then sank by 57.97% to $1.5 million in 2025, then climbed by 9.9% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 247,000.00 |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 3.48 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Mar 31, 2024 | 5.65 Mn |
| Dec 31, 2023 | 3.05 Mn |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 976,000.00 |
| Dec 31, 2022 | 7.24 Mn |
| Sep 30, 2022 | 71,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Dec 31, 2021 | 5.89 Mn |
| Sep 30, 2021 | 3.86 Mn |
| Jun 30, 2021 | 69,000.00 |